In addition, Fei et al. showed that eupatilin inhibits cell invasion by regulating the RECK/MMP pathway in glioblastoma, and the inhibitory effect on MMP-2 was significant, but relatively weak on MMP-9, suggesting the possibility of a differential regulatory mechanism for each cancer type [40]. Here, MMP9 is linked to glioblastoma.